[go: up one dir, main page]

RU99119123A - METHOD FOR TREATING CHRONIC VIRAL HEPATITIS - Google Patents

METHOD FOR TREATING CHRONIC VIRAL HEPATITIS

Info

Publication number
RU99119123A
RU99119123A RU99119123/14A RU99119123A RU99119123A RU 99119123 A RU99119123 A RU 99119123A RU 99119123/14 A RU99119123/14 A RU 99119123/14A RU 99119123 A RU99119123 A RU 99119123A RU 99119123 A RU99119123 A RU 99119123A
Authority
RU
Russia
Prior art keywords
treating chronic
viral hepatitis
chronic viral
week
day
Prior art date
Application number
RU99119123/14A
Other languages
Russian (ru)
Other versions
RU2180235C2 (en
Inventor
Марина Анатольевна Внушинская
Эльвира Ивановна Белобородова
Альберт Самойлович Саратиков
Original Assignee
Сибирский государственный медицинский университет
Filing date
Publication date
Application filed by Сибирский государственный медицинский университет filed Critical Сибирский государственный медицинский университет
Priority to RU99119123A priority Critical patent/RU2180235C2/en
Priority claimed from RU99119123A external-priority patent/RU2180235C2/en
Publication of RU99119123A publication Critical patent/RU99119123A/en
Application granted granted Critical
Publication of RU2180235C2 publication Critical patent/RU2180235C2/en

Links

Claims (1)

Способ лечения хронических вирусных гепатитов, включающий определение стадии вирусного поражения печени путем проведения биохимических серологических, морфологических исследований, и при определении репликативной фазы развития вируса назначение противовирусного препарата, отличающийся тем, что в качестве противовирусного препарата назначают индуктор интерферона йодантипирин, в дозе 200 мг/сут 4 раза в неделю в течение 6 месяцев, причем на протяжении всего курса лечения каждые две недели проводят контроль клинических синдромов, уровня трансаминаз, и при нормализации показателей дозу снижают до 100 мг/сут 3-4 раза в неделю.A method of treating chronic viral hepatitis, including determining the stage of viral liver damage by conducting biochemical serological, morphological studies, and when determining the replicative phase of the development of the virus, the appointment of an antiviral drug, characterized in that an interferon inducer iodantipyrine is prescribed as an antiviral drug, at a dose of 200 mg / day 4 times a week for 6 months, and during the entire course of treatment every two weeks, clinical syndromes are monitored, transaminase, and normalization of the dose reduced to 100 mg / day, 3-4 times a week.
RU99119123A 1999-09-03 1999-09-03 Method for treating the cases of chronic virus hepatitis RU2180235C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99119123A RU2180235C2 (en) 1999-09-03 1999-09-03 Method for treating the cases of chronic virus hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99119123A RU2180235C2 (en) 1999-09-03 1999-09-03 Method for treating the cases of chronic virus hepatitis

Publications (2)

Publication Number Publication Date
RU99119123A true RU99119123A (en) 2001-06-27
RU2180235C2 RU2180235C2 (en) 2002-03-10

Family

ID=20224650

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99119123A RU2180235C2 (en) 1999-09-03 1999-09-03 Method for treating the cases of chronic virus hepatitis

Country Status (1)

Country Link
RU (1) RU2180235C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008123590A (en) * 2008-06-17 2009-12-27 Владимир Николаевич Худолей (RU) MEANS WITH MEMBRANO-STABILIZING EFFECT

Similar Documents

Publication Publication Date Title
Finter et al. The use of interferon-α in virus infections
RU2007119725A (en) MEDICINAL FORMS
DK1001801T3 (en) Product comprising at least one double-chain RNA combined with at least one interferon for the treatment of viral hepatitis
WO2006016930A3 (en) Methods for treating hcv infection
HUP0003131A2 (en) Polyethylene glycol-interferon alpha conjugates for therapy of infection
EA199800674A1 (en) METHOD OF REPEATED TREATMENT OF PATIENTS WITH HEPATITIS C
GB2355932B (en) A pharmaceutical formulation suitable for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation
JP2019505553A5 (en)
WO2005067454A3 (en) Combination therapy for treating hepatitis c virus infection
RU99119123A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS
DK1115420T3 (en) Treatment of hepatitis B with thymosin-alpha-1 and lamivudine
EE9400068A (en) Mixtures for the treatment of hepatitis B virus (HBV) infection and diseases caused by it and the process of their preparation
NO953473D0 (en) Method of treating hepatitis C in non-responders to interferon therapy
Saval et al. Lichen Planus Induced by Interferon-a-2B Therapy in a Patient with Cutaneous Malignant Melanoma
RU2002102025A (en) A method for the treatment of patients with chronic viral hepatitis C
US6667033B1 (en) Therapeutic agent for chronic hepatitis B
RU95114168A (en) A MEANS POSSIBILITY TO PURPOSE ADVERSE EFFECTS OF INTEGRATED AND COMBINED TREATMENT OF MALIGNANT NEW FORMATIONS, TREATMENT OF HEPATITIS, AS VIRUS, AND INDUSTRIATED ALIMOUS ANIMAL
RU99125410A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS
RU98109203A (en) METHOD FOR TREATING VIRAL HEPATITIS B IN CHILDREN
Schalm Treatment of chronic viral hepatitis anno 1990
AU2003304040A8 (en) Anthranilic acid derivatives useful in treating infection with hepatitis c virus
ATE348628T1 (en) TREATING HEPATITIS C WITH THYMOSIN, INTERFERON AND RIBAVIRIN
Zhangqi et al. Efficacy of treatment with small dosage Interferon for Hepatitis C virus
Bullgescu et al. The benefits of interferon treatment in chronic viral hepatitis
Jabłkowski et al. Thymic hormones reduce replication of hepatitis B virus (HBV) in a course of treatment of chronic active hepatitis B (CAHB)